BioSpring, a vertically integrated pharmaceutical company providing innovative solutions from formulation development and located in Saysetteha Development Zone, Vientiane, Laos PDR, announced that Phase 1 of its manufacturing unit has been constructed and delivered. The delivery of the manufacturing unit is constructed according to the ICH(1)-GMP(2) standard.

As one of the emerging pharmaceutical companies in Laos, BioSpring will make full use of the strategic opportunity period given by WTO to LDC(3) member TRIPS(4).